<p>德克薩斯州永久學校基金公司在最近向證券交易委員會的披露中表示，在第二季度將其在高樂氏公司（NYSE:CLX - 免費報告）股票中的持倉提高了 92.9%。該公司在此期間額外購買了 12,072 股後，持有該公司 25,063 股股票。根據其最近向證券交易委員會的備案，德克薩斯州永久學校基金公司在高樂氏的持股價值為 3,009,000 美元。</p>
<ul>
<li>3 只防御性股票，經濟不確定性持續時值得購買</li>
</ul>
<p>其他幾家對沖基金最近也買賣了該公司的股票。Total Investment Management Inc.在第二季度以約 25,000 美元的估值獲得了高樂氏的新頭寸。美國國家銀行和信託公司在第二季度將其在高樂氏股票中的持股提高了 69.5%。美國國家銀行和信託公司現在擁有 217 股該公司的股票，價值 26,000 美元，此前在此期間又購買了 89 股。NewSquare Capital LLC 在第二季度將其在高樂氏的持股增加了 567.6%。NewSquare Capital LLC 現在擁有 227 股該公司的股票，價值 27,000 美元，此前在上個季度又購買了 193 股。Ransom Advisory Ltd 在第一季度購買了高樂氏的新股份，價值約 35,000 美元。最後，Darwin Wealth Management LLC 在第二季度獲得了高樂氏的新股份，價值約 29,000 美元。機構投資者和對沖基金持有該公司 78.53% 的股票。</p>
<h2>華爾街分析師觀點</h2>
<p>CLX 已成為幾份研究報告的主題。美國銀行在 10 月 8 日的研究報告中將高樂氏的目標價從 135.00 美元下調至 125.00 美元，並對該公司設定了 “中性” 評級。法國巴黎銀行 Exane 在 11 月 4 日的研究報告中將高樂氏的目標價從 110.00 美元下調至 103.00 美元，並對該公司設定了 “表現不佳” 評級。富國銀行在 11 月 4 日的研究報告中將高樂氏的目標價從 125.00 美元下調至 117.00 美元，並對該股票設定了 “等權重” 評級。Weiss Ratings 在 10 月 14 日的研究報告中重新發布了對高樂氏的 “持有（c-）” 評級。最後，高盛集團在 10 月 1 日的報告中將高樂氏的目標價從 115.00 美元下調至 110.00 美元，並對該股票設定了 “賣出” 評級。一位投資分析師對該股票給予了買入評級，十三位分析師給予了持有評級，四位分析師給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “減持”，平均目標價為 125.00 美元。</p>
<ul>
<li>3 只提高分紅的股票——並用業績支持</li>
</ul>
<p><strong>查看我們關於 CLX 的最新研究報告</strong></p>
<h2>高樂氏價格表現</h2>
<p>高樂氏（NYSE CLX）的股票在週五開盤時為 98.31 美元。該公司的債務與股本比率為 18.01，速動比率為 0.50，流動比率為 0.76。高樂氏公司的 52 周低點為 98.20 美元，52 周高點為 165.00 美元。該公司的市值為 119.9 億美元，市盈率為 15.43，市盈率增長比率為 0.49，貝塔值為 0.57。該股票的 50 日簡單移動平均線為 107.92 美元，200 日簡單移動平均線為 118.23 美元。</p>
<ul>
<li>富國銀行升級了這 3 只股票——以下是它們的突出之處</li>
</ul>
<p>高樂氏（NYSE:CLX - 獲取免費報告）在 11 月 3 日星期一最後一次公佈季度財報。該公司報告每股收益（EPS）為 0.85 美元，超出分析師共識預期的 0.78 美元，超出 0.07 美元。高樂氏的股本回報率為 358.39%，淨利潤率為 11.68%。該公司在本季度的收入為 14.3 億美元，而共識預期為 14.1 億美元。在去年同期，該公司每股收益為 1.86 美元。該公司的季度收入較去年同期下降了 18.9%。高樂氏已將其 2026 財年的指導目標設定為 5.950-6.300 EPS。作為一個整體，股票研究分析師預測高樂氏公司在當前財年將發佈 7.15 EPS。</p>
<h2>高樂氏分紅公告</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 2 月 13 日星期五支付。1 月 28 日的登記投資者將獲得 1.24 美元的分紅。這相當於年化分紅為 4.96 美元，分紅收益率為 5.0%。該分紅的除息日期為 1 月 28 日星期三。高樂氏的分紅支付比率（DPR）為 77.86%。</p>
<h2>內部買賣</h2>
<p>在相關消息中，董事 Pierre R. Breber 在 11 月 21 日星期五的交易中購買了 4,000 股高樂氏股票。該股票的平均購買成本為每股 104.13 美元，總價值為 416,520.00 美元。交易完成後，該董事直接持有該公司 13,000 股股票，價值約為 1,353,690 美元。此次交易使其持股增加了 44.44%。該收購在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。0.63% 的股票由公司內部人士持有。</p>
<h2>高樂氏簡介</h2>
<p>（免費報告）</p>
<p>高樂氏公司是領先的消費和專業產品製造商和營銷商，旨在幫助人們照顧他們的家庭，過上健康、可持續的生活。其產品組合涵蓋清潔和家庭用品、食品和飲料、水過濾系統和貓砂，服務於零售和機構客户。該公司的旗艦漂白劑和消毒產品在美國和許多國際市場上廣為人知，幫助防止細菌在家庭、醫院、學校和企業中的傳播。</p>
<p>Clorox 的多樣化品牌陣容包括液體漂白劑和表面清潔劑、環保清潔工具、食品保存和準備用品、炭烤爐和炭塊、特色食品和飲料、寵物護理產品以及個人護理系列。</p>
<h2>進一步閲讀</h2>
<ul>
<li>五隻我們認為比 Clorox 更好的股票</li>
<li>股票平均計算器</li>
<li>Nike 在盈利上表現良好，但在中國面臨困難並遭遇關税</li>
<li>現在值得購買的三隻沃倫·巴菲特股票</li>
<li>人工智能熱潮是泡沫嗎？這兩隻分紅股票表示不是</li>
<li>對投資者來説，最重要的沃倫·巴菲特股票：他自己的股票</li>
<li>2026 年四隻高潛力 ETF：小型股、太空股票等</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMWA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Clorox 嗎？</h2>
<p>在考慮 Clorox 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，而 Clorox 並不在名單上。</p>
<p>雖然 Clorox 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

高樂氏

<p>德克薩斯州永久學校基金公司在第二季度將其在高樂氏的持股增加了 92.9%，目前擁有 25,063 股，價值 3,009,000 美元。分析師對高樂氏的評級意見不一，普遍給予 “減持” 評級，平均目標價為 125.00 美元。高樂氏報告第三季度每股收益為 0.85 美元，超出預期，但營收同比下降了 18.9%。該公司宣佈季度股息為 1.24 美元，年收益率為 5.0%</p>

<p>Texas Permanent School Fund Corp raised its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 92.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 25,063 shares of the company's stock after buying an additional 12,072 shares during the period. Texas Permanent School Fund Corp's holdings in Clorox were worth $3,009,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>德克薩斯州永久學校基金公司在最近向證券交易委員會的披露中表示，在第二季度將其在高樂氏公司（NYSE:CLX - 免費報告）股票中的持倉提高了 92.9%。該公司在此期間額外購買了 12,072 股後，持有該公司 25,063 股股票。根據其最近向證券交易委員會的備案，德克薩斯州永久學校基金公司在高樂氏的持股價值為 3,009,000 美元。</p>
</div><ul>
<li>3 Defensive Stocks to Buy as Economic Uncertainty Lingers</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只防御性股票，經濟不確定性持續時值得購買</li>
</ul>
</div><p>Several other hedge funds have also recently bought and sold shares of the company. Total Investment Management Inc. acquired a new position in Clorox in the 2nd quarter valued at about $25,000. American National Bank &amp; Trust boosted its stake in shares of Clorox by 69.5% in the second quarter. American National Bank &amp; Trust now owns 217 shares of the company's stock valued at $26,000 after purchasing an additional 89 shares during the period. NewSquare Capital LLC grew its holdings in shares of Clorox by 567.6% in the second quarter. NewSquare Capital LLC now owns 227 shares of the company's stock valued at $27,000 after purchasing an additional 193 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in Clorox during the 1st quarter worth approximately $35,000. Finally, Darwin Wealth Management LLC acquired a new stake in Clorox during the 2nd quarter worth approximately $29,000. Institutional investors and hedge funds own 78.53% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家對沖基金最近也買賣了該公司的股票。Total Investment Management Inc.在第二季度以約 25,000 美元的估值獲得了高樂氏的新頭寸。美國國家銀行和信託公司在第二季度將其在高樂氏股票中的持股提高了 69.5%。美國國家銀行和信託公司現在擁有 217 股該公司的股票，價值 26,000 美元，此前在此期間又購買了 89 股。NewSquare Capital LLC 在第二季度將其在高樂氏的持股增加了 567.6%。NewSquare Capital LLC 現在擁有 227 股該公司的股票，價值 27,000 美元，此前在上個季度又購買了 193 股。Ransom Advisory Ltd 在第一季度購買了高樂氏的新股份，價值約 35,000 美元。最後，Darwin Wealth Management LLC 在第二季度獲得了高樂氏的新股份，價值約 29,000 美元。機構投資者和對沖基金持有該公司 78.53% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>CLX has been the subject of several research reports. Bank of America dropped their price target on shares of Clorox from $135.00 to $125.00 and set a &#34;neutral&#34; rating for the company in a research note on Wednesday, October 8th. BNP Paribas Exane lowered their target price on Clorox from $110.00 to $103.00 and set an &#34;underperform&#34; rating for the company in a research note on Tuesday, November 4th. Wells Fargo &amp; Company reduced their price target on Clorox from $125.00 to $117.00 and set an &#34;equal weight&#34; rating on the stock in a research report on Tuesday, November 4th. Weiss Ratings reissued a &#34;hold (c-)&#34; rating on shares of Clorox in a research report on Tuesday, October 14th. Finally, The Goldman Sachs Group reduced their target price on shares of Clorox from $115.00 to $110.00 and set a &#34;sell&#34; rating on the stock in a report on Wednesday, October 1st. One investment analyst has rated the stock with a Buy rating, thirteen have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of &#34;Reduce&#34; and an average target price of $125.00.</p>
<div class="lb-trans"><p>CLX 已成為幾份研究報告的主題。美國銀行在 10 月 8 日的研究報告中將高樂氏的目標價從 135.00 美元下調至 125.00 美元，並對該公司設定了 “中性” 評級。法國巴黎銀行 Exane 在 11 月 4 日的研究報告中將高樂氏的目標價從 110.00 美元下調至 103.00 美元，並對該公司設定了 “表現不佳” 評級。富國銀行在 11 月 4 日的研究報告中將高樂氏的目標價從 125.00 美元下調至 117.00 美元，並對該股票設定了 “等權重” 評級。Weiss Ratings 在 10 月 14 日的研究報告中重新發布了對高樂氏的 “持有（c-）” 評級。最後，高盛集團在 10 月 1 日的報告中將高樂氏的目標價從 115.00 美元下調至 110.00 美元，並對該股票設定了 “賣出” 評級。一位投資分析師對該股票給予了買入評級，十三位分析師給予了持有評級，四位分析師給予了賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “減持”，平均目標價為 125.00 美元。</p>
</div><ul>
<li>3 Dividend Stocks Raising Payouts—and Backing It Up With Results</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只提高分紅的股票——並用業績支持</li>
</ul>
</div><p><strong>View Our Latest Research Report on CLX</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CLX 的最新研究報告</strong></p>
</div><h2>Clorox Price Performance</h2>
<div class="lb-trans"><h2>高樂氏價格表現</h2>
</div><p>Shares of NYSE CLX opened at $98.31 on Friday. The company has a debt-to-equity ratio of 18.01, a quick ratio of 0.50 and a current ratio of 0.76. The Clorox Company has a fifty-two week low of $98.20 and a fifty-two week high of $165.00. The firm has a market capitalization of $11.99 billion, a PE ratio of 15.43, a price-to-earnings-growth ratio of 0.49 and a beta of 0.57. The stock's 50-day simple moving average is $107.92 and its 200-day simple moving average is $118.23.</p>
<div class="lb-trans"><p>高樂氏（NYSE CLX）的股票在週五開盤時為 98.31 美元。該公司的債務與股本比率為 18.01，速動比率為 0.50，流動比率為 0.76。高樂氏公司的 52 周低點為 98.20 美元，52 周高點為 165.00 美元。該公司的市值為 119.9 億美元，市盈率為 15.43，市盈率增長比率為 0.49，貝塔值為 0.57。該股票的 50 日簡單移動平均線為 107.92 美元，200 日簡單移動平均線為 118.23 美元。</p>
</div><ul>
<li>Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out</li>
</ul>
<div class="lb-trans"><ul>
<li>富國銀行升級了這 3 只股票——以下是它們的突出之處</li>
</ul>
</div><p>Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the company posted $1.86 earnings per share. The firm's quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>高樂氏（NYSE:CLX - 獲取免費報告）在 11 月 3 日星期一最後一次公佈季度財報。該公司報告每股收益（EPS）為 0.85 美元，超出分析師共識預期的 0.78 美元，超出 0.07 美元。高樂氏的股本回報率為 358.39%，淨利潤率為 11.68%。該公司在本季度的收入為 14.3 億美元，而共識預期為 14.1 億美元。在去年同期，該公司每股收益為 1.86 美元。該公司的季度收入較去年同期下降了 18.9%。高樂氏已將其 2026 財年的指導目標設定為 5.950-6.300 EPS。作為一個整體，股票研究分析師預測高樂氏公司在當前財年將發佈 7.15 EPS。</p>
</div><h2>Clorox Dividend Announcement</h2>
<div class="lb-trans"><h2>高樂氏分紅公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.0%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox's dividend payout ratio (DPR) is 77.86%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 2 月 13 日星期五支付。1 月 28 日的登記投資者將獲得 1.24 美元的分紅。這相當於年化分紅為 4.96 美元，分紅收益率為 5.0%。該分紅的除息日期為 1 月 28 日星期三。高樂氏的分紅支付比率（DPR）為 77.86%。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><p>In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. 0.63% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，董事 Pierre R. Breber 在 11 月 21 日星期五的交易中購買了 4,000 股高樂氏股票。該股票的平均購買成本為每股 104.13 美元，總價值為 416,520.00 美元。交易完成後，該董事直接持有該公司 13,000 股股票，價值約為 1,353,690 美元。此次交易使其持股增加了 44.44%。該收購在向證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。0.63% 的股票由公司內部人士持有。</p>
</div><h2>Clorox Profile</h2>
<div class="lb-trans"><h2>高樂氏簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.</p>
<div class="lb-trans"><p>高樂氏公司是領先的消費和專業產品製造商和營銷商，旨在幫助人們照顧他們的家庭，過上健康、可持續的生活。其產品組合涵蓋清潔和家庭用品、食品和飲料、水過濾系統和貓砂，服務於零售和機構客户。該公司的旗艦漂白劑和消毒產品在美國和許多國際市場上廣為人知，幫助防止細菌在家庭、醫院、學校和企業中的傳播。</p>
</div><p>Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.</p>
<div class="lb-trans"><p>Clorox 的多樣化品牌陣容包括液體漂白劑和表面清潔劑、環保清潔工具、食品保存和準備用品、炭烤爐和炭塊、特色食品和飲料、寵物護理產品以及個人護理系列。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Clorox</li>
<li>Stock Average Calculator</li>
<li>Nike Beats on Earnings But Struggles in China and Faces Tariffs</li>
<li>3 Warren Buffett Stocks to Buy Now</li>
<li>Is the AI Boom a Bubble? These 2 Dividend Stocks Say No</li>
<li>The Most Important Warren Buffett Stock for Investors: His Own</li>
<li>4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Clorox 更好的股票</li>
<li>股票平均計算器</li>
<li>Nike 在盈利上表現良好，但在中國面臨困難並遭遇關税</li>
<li>現在值得購買的三隻沃倫·巴菲特股票</li>
<li>人工智能熱潮是泡沫嗎？這兩隻分紅股票表示不是</li>
<li>對投資者來説，最重要的沃倫·巴菲特股票：他自己的股票</li>
<li>2026 年四隻高潛力 ETF：小型股、太空股票等</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CLX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Clorox Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Clorox 嗎？</h2>
</div><p>Before you consider Clorox, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Clorox 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄建議客户現在購買的股票，而 Clorox 並不在名單上。</p>
</div><p>While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Clorox 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

德克薩斯永久學校基金公司增加了在高樂氏公司的持倉 $CLX